If you enjoyed this talk, consider joining the Molecular Modeling and Drug Discovery (M2D2) talks live: https://valence-discovery.github.io/M...
Abstract: Machine learning for therapeutics offer incredible opportunities for expansion, innovation, and impact. Despite promises, many challenges exist. In this talk, the speaker will first highlight two high-impact but relatively understudied directions - ML-aided clinical trial design and low-data/cross-context biomedicine. Then, he will discuss challenges arising from therapeutics ML adoption in the wild, namely, generating actionable hypotheses and user interface with domain scientists. Lastly, challenges in infrastructure, such as data and benchmark, will be looked at.
Speaker: Kexin Huang - https://www.kexinhuang.com/
Twitter Prudencio: https://twitter.com/tossouprudencio
Twitter Therence: https://twitter.com/Therence_mtl
Twitter Cas: https://twitter.com/cas_wognum
Twitter Valence Discovery: https://twitter.com/valence_ai
Fler avsnitt av Molecular Modelling and Drug Discovery
Visa alla avsnitt av Molecular Modelling and Drug DiscoveryMolecular Modelling and Drug Discovery med Valence Discovery finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
